FDA Drug Application (072011) for TRIAMTERENE AND HYDROCHLOROTHIAZIDE by SANDOZ

Back to FDA Applications sponsored by SANDOZ

Application Number072011
Product Number001
FormTABLET;ORAL
Dosage50MG;75MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTRIAMTERENE AND HYDROCHLOROTHIAZIDE
Active IngredientHYDROCHLOROTHIAZIDE; TRIAMTERENE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient TRIAMTERENE5


Back to FDA Applications sponsored by SANDOZ